Management of Polycystic Ovary Syndrome (PCOS) in Adolescents
DOI:
https://doi.org/10.33448/rsd-v11i15.37118Keywords:
Polycystic Ovary Syndrome; Adolescent; Life Style; Therapeutic.Abstract
Introduction: It is of great importance to acknowledge the diagnostic criteria for the Polycystic Ovary Syndrome in adolescence, for an opportune diagnosis and appropriate therapeutic, preventing unnecessary treatment and lack of intervention. Objective: To investigate PCOS’s management in adolescents. Methods: Integrative revision based on 23 articles in English selected from the database: Pubmed/Medline and Cocharane, in the last 10 years. Clinical trials, meta-analyses, and systematic revisions were included, and those articles referring to PCOS in adult women, and those that weren't about the treatment, were excluded. Results: The selected articles cover PCOS`s therapeutic in adolescents. For the clinical findings of hyperandrogenism and menstrual irregularity, combined oral contraceptives (COC) can be used as the first choice however, other antiandrogens are also effective, such as spironolactone. Besides, the association of topic therapy in the treatment of acne, along with physical methods such as depilation, for hirsutism, has shown good results. Regarding obesity, lifestyle change is the heart of the therapeutic but, drugs namely metformin, orlistat, and fluoxetine help to reduce body weight. Thus, for insulin resistance, metformin is the elected to intervene, having glitazones as a second choice. Conclusion: The treatment basis of PCOS in adolescents is lifestyle change. The use of metformin has shown a reduction of the Body Mass Index (BMI), associated with the lowering of blood glucose and improvements in the total cholesterol and LDL levels. The treatment with COCs resulted in modest cycle regulation, and reduction of acne and hirsutism, being cosmetics also used.
References
Arentz, S., Smith C., Abbott, J., Fahey P., Cheema B., & Bensoussan, A. (2017). Combined Lifestyle and Herbal Medicine in Overweight Women with Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial. Phytotherapy Research, 31(9), 1330-1340. https://doi.org/10.1002/ptr.5858.
Bredella, M., McManus, S., & Misra, M. (2013). Impact of metformin monotherapy versus metformin with estrogen-progesterone on lipids in adolescent girls with the polycystic ovarian syndrome. Clin Endocrinol (Oxf), 79(2), 199–203. https://doi.org/10.1111/cen.12028.
Calcaterra, V., Verduci, E., Magenes, V., Todisco, C., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., & Zuccotti, G. (2021). Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrientes, 13(6), 1848. https://doi.org/10.3390/nu13061848.
Chung, J., Yiu, A., Chung, T., & Chan, S. (2014). A Randomized Crossover Study of Medroxyprogesterone Acetate and Diane-35 in Adolescent Girls with Polycystic Ovarian Syndrome. Journal of Pediatric and Adolescent Gynecology, 27(3), 166-171. http://dx.doi.org/10.1016/j.jpag.2013.09.011.
Coles, N., Birken C., & Hamilton, J. (2016). Emerging treatments for severe obesity in children and adolescents. BMJ, 354 https://doi.org/10.1136/bmj.i4116.
Goodarzi, M., Dumesic, D., Chazenbalk, G., & Azziz, R. (2011). Polycystic ovary syndrome: etiology, pathogenesis, and diagnosis. Nature Reviews Endocrinology, 7, 219–231. https://doi.org/10.1038/nrendo.2010.217.
Ibáñez, L., Oberfield, S., Witchel, S., Auchus, R., Chang, R., Codner, E., Dabadghaoh, P., Darendeliler, F., Elbarbary, N., Gambinerik, A., Rudaz, C., Hoeger, K., Bermejo, A., Tao, R., Yildiz, B., Alkhayyat, H., Deeb, A., Joel, D., Horikawa, R., Zegher, F., & Lee, P. (2017). An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Hormone Research in Pediatrics, 88, 371-395. https://doi.org/10.1159/000479371.
Ladson, G., Dodson W., Sweet S., Archibong A., Kunselman A., Demers L., Lee P., Williams N., Coney P., & Legro R. (2011). Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study. Fertil Steril 95(8), 2595–8.e1-6. https://doi.org/10.1016/j.fertnstert.2011.05.048.
Martins, M. d. F. M. (2018). Estudos de revisão de literatura. Fiocruz/Icict, 37. Trabalho apresentado no Curso de Acesso à Informação Científica e Tecnológica em Saúde. Modalidade: Qualificação. https://www.arca.fiocruz.br/handle/icict/29213.
Marzouk, T. M. F., & Sayed, A.W. A., (2015). Effect of dietary weight loss on menstrual regularity in obese young adult females with polycystic ovary syndrome. Journal of Pediatric and Adolescent Gynecology, 28(6) 457-461. https://doi.org/10.1016/j.jpag.2015.01.002.
Mead, E., Atkinson, G., Richter, B., Metzendorf, M. I., Baur, L., Finer, N., Corpeleijn, E., O'Malley C., & Ells, L. J., (2016). Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst https://doi.org/10.1002/14651858.CD012436.
Nicandri, K., & Hoeger, K. (2012). Diagnosis and treatment of polycystic ovarian syndrome in adolescents. Current Opinion in Endocrinology, Diabetes, and Obesity, 19(6), 497-504. https://doi.org/10.1097/MED.0b013e32835a1a03.
Nicolaides, N., Matheou, A., Vlachou, A., Neocleous, V., & Skordis, N. (2020). Polycystic ovarian syndrome in adolescents: from diagnostic criteria to therapeutic management. Pediatric Endocrinology Update, 91 (3), 2020085. https://doi.org/10.23750/abm.v91i3.10162.
Palomba, S., Materazzo, C., Falbo, A., Orio, F., La Sala, G., & Sultan, C. (2014). Metformin, oral contraceptives, or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review. Gynecological Endocrinology, 30(5), 335-340. https://doi.org/10.3109/09513590.2013.876001.
Roberts, E., Nowsheen, S., Davis, D., Hand, J., Tollefson, M., & Wetter, D. (2021). Use of spironolactone to treat acne in adolescent females. Pediatric Dermatology, 38(1), 72-76. https://doi.org/10.1111/pde.14391.
Rosenfield, R. (2020). Perspectives on the International Recommendations for the Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescence. Journal of Pediatric & Adolescent Gynecology, 33(5), 445-447. https://doi.org/10.1016/j.jpag.2020.06.017.
Sanchez-Garrido, M., & Tena-Sempere, M. (2020). Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Molecular Metabolism, 35, 100937.https://doi.org/10.1016/j.molmet.2020.01.001.
Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, 789. Obstetrics & Gynecology, 134(4), 106-114. https://doi.org/10.1097/AOG.0000000000003475.
Souza, M. T., Silva, M. D., & Carvalho, R. (2010). Revisão integrativa: o que é e como fazer. Einstein 1(8), 102-106. https://doi.org/10.1590/S1679-45082010RW1134.
Spritzer, P., & Motta, A. (2015). Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment. The International Journal of Clinical Practice, 69(11), 1236–1246. https://doi.org/10.1111/ijcp.12719.
Stabile, G., Borrielli I., Artenisio, A., Bruno, L., Benvenga S., Giunta, L., La Marca, A., Volpe, A., & Pizzo, A. (2014). Effects of the Insulin Sensitizer Pioglitazone on Menstrual Irregularity, Insulin Resistance and Hyperandrogenism in Young Women with Polycystic Ovary Syndrome. Journal of Pediatric and Adolescent Gynecology, 27(3), 177-182. http://dx.doi.org/10.1016/j.jpag.2013.09.015.
Teede, H., Misso, M., Costello, M., Dokras, A., Laven, J., Moran, L., Piltonen, T., & Norman, R. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction 33(9) 1602-1618. https://doi.org/10.1093/humrep/dey256.
Torres-Zegarra, C., Sundararajan, D., Benson, J., Seagle, H., Witten, M. N., Walders-Abramson, N., Simon, S., Huguelet, P., & Nokoff, N. (2021). Care for Adolescents With Polycystic Ovary Syndrome: Development and Prescribing Patterns of a Multidisciplinary Clinic. Journal of Pediatric and Adolescent Gynecology, 34, 617–625. https://doi.org/10.1016/j.jpag.2021.02.002.
Vilmann, L., Thisted, E., & Holm J. (2012). Development of Obesity and Polycystic Ovary Syndrome in Adolescents. Hormone Research in Pediatrics, 78, 269–278. https://doi.org/10.1159/000345310.
Williams, R., Ong K., & Dunger, D. (2013). Polycystic ovarian syndrome during puberty and adolescence. Molecular and Cellular Endocrinology, 373 (1-2), 61-67. http://dx.doi.org/10.1016/j.mce.2013.01.005.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Paula Romana Bessa; Elza Thereza Gianvecchio Barros Carvalho; Osmar Vicente Ferreira Filho; Pedro Henrique Carvalho Viana Silva; Márcia Cristina Terra de Siqueira Peres
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
